Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Asthma | 235 | 2024 | 6172 | 21.640 |
Why?
|
Allergens | 88 | 2024 | 1402 | 12.030 |
Why?
|
Air Pollution, Indoor | 51 | 2024 | 893 | 10.680 |
Why?
|
Schools | 51 | 2024 | 1480 | 8.510 |
Why?
|
Environmental Exposure | 79 | 2024 | 4412 | 7.980 |
Why?
|
Hypersensitivity | 36 | 2024 | 1155 | 7.290 |
Why?
|
Anti-Asthmatic Agents | 30 | 2024 | 565 | 5.850 |
Why?
|
Food Hypersensitivity | 23 | 2024 | 697 | 5.460 |
Why?
|
Urban Population | 36 | 2024 | 2022 | 5.350 |
Why?
|
Bronchodilator Agents | 17 | 2022 | 506 | 3.420 |
Why?
|
Cockroaches | 16 | 2022 | 97 | 3.090 |
Why?
|
Adrenal Cortex Hormones | 34 | 2024 | 1869 | 2.830 |
Why?
|
Dust | 16 | 2024 | 483 | 2.660 |
Why?
|
Skin Tests | 19 | 2020 | 637 | 2.590 |
Why?
|
Child | 198 | 2024 | 79806 | 2.590 |
Why?
|
Immunoglobulin E | 27 | 2023 | 1484 | 2.520 |
Why?
|
Eczema | 7 | 2024 | 245 | 2.490 |
Why?
|
Egg Hypersensitivity | 5 | 2020 | 47 | 2.350 |
Why?
|
Dermatitis, Atopic | 11 | 2024 | 716 | 2.260 |
Why?
|
Fungi | 13 | 2023 | 339 | 2.150 |
Why?
|
Housing | 14 | 2023 | 665 | 1.930 |
Why?
|
Pest Control | 4 | 2019 | 29 | 1.760 |
Why?
|
Endotoxins | 5 | 2018 | 521 | 1.580 |
Why?
|
Biological Products | 7 | 2023 | 916 | 1.480 |
Why?
|
Hypersensitivity, Immediate | 9 | 2024 | 345 | 1.440 |
Why?
|
School Health Services | 7 | 2022 | 382 | 1.410 |
Why?
|
Child, Preschool | 79 | 2024 | 42063 | 1.410 |
Why?
|
Desensitization, Immunologic | 8 | 2022 | 534 | 1.370 |
Why?
|
Milk Hypersensitivity | 3 | 2020 | 78 | 1.370 |
Why?
|
Spirometry | 11 | 2023 | 924 | 1.350 |
Why?
|
Air Pollutants | 17 | 2024 | 2844 | 1.350 |
Why?
|
Nitrogen Dioxide | 5 | 2024 | 512 | 1.320 |
Why?
|
Ibuprofen | 3 | 2021 | 229 | 1.280 |
Why?
|
Humans | 321 | 2024 | 760621 | 1.270 |
Why?
|
Pyroglyphidae | 7 | 2018 | 88 | 1.250 |
Why?
|
Adrenergic beta-2 Receptor Agonists | 4 | 2019 | 108 | 1.230 |
Why?
|
Air Pollution | 8 | 2024 | 2317 | 1.170 |
Why?
|
Respiratory Sounds | 8 | 2021 | 697 | 1.170 |
Why?
|
Urban Health | 6 | 2019 | 533 | 1.110 |
Why?
|
Cats | 12 | 2018 | 976 | 1.110 |
Why?
|
Administration, Inhalation | 24 | 2022 | 1156 | 1.100 |
Why?
|
Viruses | 2 | 2021 | 376 | 1.100 |
Why?
|
Psychology | 2 | 2019 | 355 | 1.060 |
Why?
|
Forced Expiratory Volume | 19 | 2024 | 1809 | 1.040 |
Why?
|
Respiratory Function Tests | 16 | 2024 | 1683 | 1.010 |
Why?
|
Morbidity | 15 | 2023 | 1765 | 0.970 |
Why?
|
Adolescent | 89 | 2024 | 87810 | 0.950 |
Why?
|
Ovomucin | 2 | 2013 | 7 | 0.910 |
Why?
|
Snoring | 2 | 2024 | 206 | 0.870 |
Why?
|
Antigens, Dermatophagoides | 7 | 2021 | 97 | 0.850 |
Why?
|
Caregivers | 9 | 2024 | 2224 | 0.850 |
Why?
|
Air Microbiology | 3 | 2019 | 94 | 0.850 |
Why?
|
Anaphylaxis | 5 | 2019 | 755 | 0.800 |
Why?
|
Phthalic Acids | 2 | 2024 | 476 | 0.800 |
Why?
|
Rodent Control | 1 | 2021 | 15 | 0.790 |
Why?
|
Mice | 38 | 2024 | 81208 | 0.780 |
Why?
|
Dogs | 11 | 2022 | 3841 | 0.780 |
Why?
|
Rodenticides | 2 | 2021 | 21 | 0.780 |
Why?
|
Eggs | 2 | 2013 | 183 | 0.770 |
Why?
|
Male | 136 | 2024 | 359744 | 0.760 |
Why?
|
Spores, Fungal | 2 | 2019 | 90 | 0.760 |
Why?
|
Eosinophils | 10 | 2024 | 944 | 0.730 |
Why?
|
Nut Hypersensitivity | 2 | 2010 | 32 | 0.730 |
Why?
|
Female | 139 | 2024 | 391270 | 0.730 |
Why?
|
Pregnenediones | 4 | 2022 | 29 | 0.720 |
Why?
|
Leukotriene Antagonists | 4 | 2016 | 123 | 0.710 |
Why?
|
Rodentia | 3 | 2019 | 260 | 0.710 |
Why?
|
Cities | 6 | 2024 | 538 | 0.710 |
Why?
|
Ozone | 1 | 2023 | 477 | 0.690 |
Why?
|
Virus Diseases | 2 | 2017 | 720 | 0.690 |
Why?
|
Animals | 75 | 2024 | 167963 | 0.690 |
Why?
|
Acetaminophen | 4 | 2021 | 553 | 0.680 |
Why?
|
Nitric Oxide | 7 | 2023 | 2141 | 0.660 |
Why?
|
Rhinovirus | 5 | 2023 | 202 | 0.660 |
Why?
|
Alternaria | 1 | 2019 | 42 | 0.650 |
Why?
|
Climate Change | 3 | 2017 | 488 | 0.650 |
Why?
|
Anti-Allergic Agents | 2 | 2020 | 149 | 0.650 |
Why?
|
Vehicle Emissions | 2 | 2024 | 653 | 0.640 |
Why?
|
Epinephrine | 3 | 2017 | 791 | 0.640 |
Why?
|
Antibodies, Blocking | 1 | 2019 | 242 | 0.630 |
Why?
|
Mentors | 1 | 2024 | 661 | 0.620 |
Why?
|
Acute Chest Syndrome | 1 | 2018 | 32 | 0.620 |
Why?
|
Hospitals, Pediatric | 2 | 2018 | 1854 | 0.610 |
Why?
|
Insect Bites and Stings | 2 | 2017 | 70 | 0.600 |
Why?
|
Albuterol | 5 | 2019 | 212 | 0.600 |
Why?
|
Respiratory Tract Diseases | 2 | 2013 | 748 | 0.580 |
Why?
|
Exhalation | 2 | 2016 | 181 | 0.580 |
Why?
|
Oxidants, Photochemical | 1 | 2017 | 76 | 0.580 |
Why?
|
Students | 9 | 2023 | 1730 | 0.580 |
Why?
|
Inhalation Exposure | 1 | 2020 | 429 | 0.570 |
Why?
|
Medication Adherence | 7 | 2020 | 2165 | 0.550 |
Why?
|
Policy | 2 | 2019 | 511 | 0.550 |
Why?
|
Maximal Midexpiratory Flow Rate | 2 | 2016 | 76 | 0.550 |
Why?
|
Double-Blind Method | 22 | 2024 | 12427 | 0.540 |
Why?
|
Antibodies, Anti-Idiotypic | 2 | 2015 | 356 | 0.540 |
Why?
|
Jews | 1 | 2018 | 364 | 0.540 |
Why?
|
Obesity | 10 | 2023 | 12922 | 0.530 |
Why?
|
Plant Proteins | 2 | 2021 | 370 | 0.530 |
Why?
|
Severity of Illness Index | 25 | 2024 | 15840 | 0.520 |
Why?
|
Interleukin-4 Receptor alpha Subunit | 4 | 2022 | 57 | 0.520 |
Why?
|
Bronchoconstriction | 1 | 2016 | 139 | 0.510 |
Why?
|
Toxocariasis | 1 | 2015 | 12 | 0.500 |
Why?
|
Infant | 30 | 2024 | 36060 | 0.500 |
Why?
|
Picornaviridae Infections | 3 | 2023 | 94 | 0.490 |
Why?
|
Enterocolitis | 3 | 2021 | 106 | 0.490 |
Why?
|
Particulate Matter | 10 | 2024 | 2559 | 0.480 |
Why?
|
Terbutaline | 1 | 2014 | 23 | 0.470 |
Why?
|
Mycoses | 1 | 2017 | 387 | 0.470 |
Why?
|
Prevalence | 12 | 2024 | 15687 | 0.460 |
Why?
|
United States | 33 | 2024 | 72461 | 0.460 |
Why?
|
Trees | 1 | 2014 | 59 | 0.450 |
Why?
|
Asthma, Exercise-Induced | 1 | 2013 | 23 | 0.450 |
Why?
|
Peanut Hypersensitivity | 2 | 2021 | 211 | 0.450 |
Why?
|
Egg White | 1 | 2013 | 16 | 0.450 |
Why?
|
Milk | 3 | 2020 | 443 | 0.450 |
Why?
|
Immune System | 1 | 2019 | 798 | 0.440 |
Why?
|
Sesamum | 2 | 2010 | 20 | 0.440 |
Why?
|
Sputum | 5 | 2024 | 503 | 0.440 |
Why?
|
Rhinitis, Allergic, Seasonal | 1 | 2014 | 104 | 0.440 |
Why?
|
Nasal Mucosa | 2 | 2019 | 412 | 0.430 |
Why?
|
Environmental Monitoring | 6 | 2024 | 1441 | 0.430 |
Why?
|
Pneumonia | 2 | 2022 | 2131 | 0.430 |
Why?
|
Immune Tolerance | 3 | 2020 | 2299 | 0.430 |
Why?
|
Receptors, Adrenergic, beta-2 | 1 | 2014 | 213 | 0.420 |
Why?
|
Parents | 5 | 2014 | 3549 | 0.420 |
Why?
|
Ipratropium | 2 | 2016 | 19 | 0.420 |
Why?
|
Social Class | 4 | 2024 | 2005 | 0.410 |
Why?
|
Immunization | 4 | 2010 | 1227 | 0.410 |
Why?
|
Acetates | 3 | 2019 | 321 | 0.410 |
Why?
|
Antibodies, Monoclonal | 5 | 2023 | 9185 | 0.410 |
Why?
|
Quality of Life | 14 | 2024 | 13308 | 0.410 |
Why?
|
Genes, Regulator | 1 | 2013 | 374 | 0.400 |
Why?
|
Pesticides | 1 | 2015 | 293 | 0.400 |
Why?
|
Patient Education as Topic | 3 | 2019 | 2315 | 0.390 |
Why?
|
Education | 1 | 2015 | 534 | 0.390 |
Why?
|
Radon | 2 | 2023 | 84 | 0.390 |
Why?
|
Immunity | 1 | 2017 | 998 | 0.390 |
Why?
|
Computer-Assisted Instruction | 1 | 2015 | 362 | 0.390 |
Why?
|
Pets | 3 | 2019 | 47 | 0.380 |
Why?
|
Health Surveys | 2 | 2019 | 4063 | 0.380 |
Why?
|
Prospective Studies | 26 | 2024 | 54303 | 0.380 |
Why?
|
Prolactin | 1 | 2013 | 621 | 0.380 |
Why?
|
Socioeconomic Factors | 6 | 2019 | 7806 | 0.360 |
Why?
|
Cross Reactions | 2 | 2023 | 818 | 0.360 |
Why?
|
Edema | 1 | 2015 | 769 | 0.360 |
Why?
|
Bronchiolitis | 1 | 2017 | 481 | 0.360 |
Why?
|
Minority Groups | 8 | 2022 | 1201 | 0.360 |
Why?
|
Specimen Handling | 1 | 2015 | 707 | 0.360 |
Why?
|
Antibody Specificity | 1 | 2012 | 1060 | 0.350 |
Why?
|
Cooking | 1 | 2012 | 311 | 0.350 |
Why?
|
School Nursing | 2 | 2022 | 33 | 0.350 |
Why?
|
Risk | 8 | 2020 | 9631 | 0.350 |
Why?
|
Phenols | 2 | 2024 | 514 | 0.350 |
Why?
|
Eosinophilia | 3 | 2023 | 559 | 0.350 |
Why?
|
Monitoring, Physiologic | 2 | 2024 | 1784 | 0.350 |
Why?
|
Bacteria | 2 | 2023 | 2199 | 0.340 |
Why?
|
Rhinitis | 4 | 2014 | 746 | 0.340 |
Why?
|
Safety | 2 | 2014 | 1148 | 0.340 |
Why?
|
Phenotype | 8 | 2020 | 16546 | 0.340 |
Why?
|
Buffaloes | 1 | 2009 | 14 | 0.330 |
Why?
|
Interleukin-6 | 6 | 2023 | 3215 | 0.330 |
Why?
|
Bacterial Infections | 1 | 2017 | 1403 | 0.330 |
Why?
|
Occupational Diseases | 1 | 2017 | 1486 | 0.330 |
Why?
|
Genes | 1 | 2013 | 1845 | 0.330 |
Why?
|
Residence Characteristics | 2 | 2022 | 2062 | 0.330 |
Why?
|
Epigenesis, Genetic | 3 | 2019 | 3758 | 0.320 |
Why?
|
Quinolines | 3 | 2019 | 759 | 0.310 |
Why?
|
Disease Progression | 14 | 2022 | 13502 | 0.310 |
Why?
|
Allergy and Immunology | 3 | 2024 | 175 | 0.310 |
Why?
|
Respiratory Hypersensitivity | 3 | 2016 | 272 | 0.310 |
Why?
|
Vital Capacity | 4 | 2019 | 965 | 0.310 |
Why?
|
Cohort Studies | 23 | 2024 | 41335 | 0.300 |
Why?
|
Polymorphism, Genetic | 2 | 2017 | 4291 | 0.290 |
Why?
|
Anti-Infective Agents | 1 | 2015 | 981 | 0.290 |
Why?
|
Adult | 54 | 2024 | 219994 | 0.290 |
Why?
|
Boston | 8 | 2018 | 9280 | 0.280 |
Why?
|
Pollen | 3 | 2014 | 81 | 0.280 |
Why?
|
Glucocorticoids | 5 | 2022 | 2145 | 0.280 |
Why?
|
Breath Tests | 5 | 2023 | 297 | 0.270 |
Why?
|
Vitamins | 3 | 2021 | 1634 | 0.270 |
Why?
|
Suburban Population | 1 | 2005 | 54 | 0.250 |
Why?
|
Tumor Cells, Cultured | 1 | 2013 | 6131 | 0.250 |
Why?
|
Enterovirus Infections | 2 | 2023 | 74 | 0.250 |
Why?
|
Length of Stay | 2 | 2018 | 6479 | 0.250 |
Why?
|
Treatment Outcome | 20 | 2024 | 65017 | 0.250 |
Why?
|
Environmental Pollutants | 3 | 2024 | 1266 | 0.250 |
Why?
|
Immunotherapy | 3 | 2020 | 4642 | 0.250 |
Why?
|
Respiratory Insufficiency | 1 | 2014 | 1231 | 0.250 |
Why?
|
Risk Factors | 22 | 2024 | 74359 | 0.250 |
Why?
|
Disease Susceptibility | 5 | 2021 | 1791 | 0.240 |
Why?
|
Animals, Domestic | 3 | 2010 | 57 | 0.240 |
Why?
|
Pilot Projects | 7 | 2019 | 8555 | 0.240 |
Why?
|
Randomized Controlled Trials as Topic | 10 | 2024 | 10344 | 0.240 |
Why?
|
Peak Expiratory Flow Rate | 3 | 2018 | 144 | 0.240 |
Why?
|
Eosinophil Peroxidase | 1 | 2024 | 21 | 0.240 |
Why?
|
Vitamin D Deficiency | 3 | 2020 | 1379 | 0.240 |
Why?
|
Th2 Cells | 3 | 2024 | 1047 | 0.230 |
Why?
|
Food | 3 | 2018 | 771 | 0.230 |
Why?
|
Conjunctivitis, Allergic | 1 | 2005 | 123 | 0.230 |
Why?
|
Mites | 2 | 2017 | 46 | 0.230 |
Why?
|
Lung | 13 | 2024 | 9994 | 0.230 |
Why?
|
Osteolysis | 1 | 2006 | 274 | 0.230 |
Why?
|
Parabens | 1 | 2024 | 114 | 0.220 |
Why?
|
Solar Activity | 1 | 2023 | 44 | 0.220 |
Why?
|
Poverty | 7 | 2024 | 2695 | 0.220 |
Why?
|
Mass Screening | 2 | 2019 | 5423 | 0.220 |
Why?
|
Azetidines | 1 | 2024 | 141 | 0.220 |
Why?
|
Research Design | 9 | 2024 | 6180 | 0.210 |
Why?
|
Interleukin-4 | 2 | 2024 | 1130 | 0.210 |
Why?
|
Epithelial Cells | 1 | 2015 | 3663 | 0.210 |
Why?
|
Australia | 2 | 2024 | 1289 | 0.210 |
Why?
|
Age Factors | 8 | 2024 | 18416 | 0.210 |
Why?
|
Attitude to Health | 1 | 2012 | 2029 | 0.210 |
Why?
|
Practice Guidelines as Topic | 6 | 2018 | 7475 | 0.210 |
Why?
|
Family Characteristics | 2 | 2024 | 1001 | 0.210 |
Why?
|
Cholecalciferol | 2 | 2020 | 550 | 0.210 |
Why?
|
Churg-Strauss Syndrome | 1 | 2003 | 74 | 0.200 |
Why?
|
Drug Prescriptions | 1 | 2012 | 1673 | 0.200 |
Why?
|
Arthroplasty, Replacement | 1 | 2006 | 310 | 0.200 |
Why?
|
Endogenous Retroviruses | 1 | 2023 | 111 | 0.200 |
Why?
|
DNA Methylation | 3 | 2023 | 4373 | 0.200 |
Why?
|
Ovalbumin | 1 | 2024 | 674 | 0.200 |
Why?
|
Spain | 1 | 2023 | 488 | 0.200 |
Why?
|
Stress, Psychological | 1 | 2017 | 4446 | 0.200 |
Why?
|
Anti-Inflammatory Agents | 2 | 2020 | 1796 | 0.200 |
Why?
|
Pandemics | 7 | 2022 | 8624 | 0.190 |
Why?
|
Inflammation | 10 | 2024 | 10756 | 0.190 |
Why?
|
Environmental Illness | 1 | 2001 | 34 | 0.190 |
Why?
|
Pulmonary Eosinophilia | 1 | 2022 | 78 | 0.190 |
Why?
|
Basophils | 1 | 2024 | 404 | 0.190 |
Why?
|
Environment | 2 | 2018 | 1118 | 0.190 |
Why?
|
Muscarinic Antagonists | 1 | 2022 | 138 | 0.190 |
Why?
|
Cross-Sectional Studies | 9 | 2024 | 25942 | 0.190 |
Why?
|
Pruritus | 2 | 2023 | 377 | 0.190 |
Why?
|
Cysteine Endopeptidases | 2 | 2021 | 548 | 0.190 |
Why?
|
Cross-Over Studies | 5 | 2019 | 2061 | 0.190 |
Why?
|
Antiviral Agents | 3 | 2017 | 3061 | 0.190 |
Why?
|
Dyspnea | 4 | 2024 | 1352 | 0.180 |
Why?
|
Bone Transplantation | 1 | 2006 | 922 | 0.180 |
Why?
|
Epitope Mapping | 1 | 2021 | 297 | 0.180 |
Why?
|
Young Adult | 19 | 2024 | 58741 | 0.180 |
Why?
|
Comorbidity | 6 | 2024 | 10551 | 0.180 |
Why?
|
Genomics | 2 | 2018 | 5794 | 0.180 |
Why?
|
Baltimore | 2 | 2019 | 230 | 0.180 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2015 | 3986 | 0.180 |
Why?
|
Epitopes | 2 | 2021 | 2503 | 0.180 |
Why?
|
Respiratory Tract Infections | 2 | 2020 | 1007 | 0.180 |
Why?
|
Mucus | 1 | 2022 | 342 | 0.170 |
Why?
|
Nonlinear Dynamics | 1 | 2022 | 494 | 0.170 |
Why?
|
Filtration | 2 | 2011 | 229 | 0.170 |
Why?
|
Tosyl Compounds | 1 | 2000 | 112 | 0.170 |
Why?
|
Triamcinolone | 1 | 2019 | 68 | 0.170 |
Why?
|
Health Services | 2 | 2017 | 753 | 0.170 |
Why?
|
Leukocyte Count | 5 | 2024 | 1600 | 0.170 |
Why?
|
Seasons | 3 | 2019 | 1522 | 0.170 |
Why?
|
Nasal Provocation Tests | 1 | 1998 | 9 | 0.160 |
Why?
|
Particle Size | 3 | 2019 | 1644 | 0.160 |
Why?
|
National Heart, Lung, and Blood Institute (U.S.) | 2 | 2019 | 322 | 0.160 |
Why?
|
Sleep Apnea Syndromes | 2 | 2024 | 974 | 0.160 |
Why?
|
Growth Differentiation Factor 15 | 1 | 2020 | 196 | 0.160 |
Why?
|
Infant, Newborn | 7 | 2024 | 26181 | 0.160 |
Why?
|
Extravascular Lung Water | 1 | 2018 | 20 | 0.160 |
Why?
|
Retinal Detachment | 1 | 2023 | 427 | 0.150 |
Why?
|
Dermatophagoides pteronyssinus | 1 | 2018 | 11 | 0.150 |
Why?
|
Blood Gas Monitoring, Transcutaneous | 1 | 2018 | 34 | 0.150 |
Why?
|
Airway Obstruction | 1 | 2023 | 662 | 0.150 |
Why?
|
Azithromycin | 2 | 2019 | 200 | 0.150 |
Why?
|
Larynx | 1 | 2023 | 492 | 0.150 |
Why?
|
Body Mass Index | 6 | 2022 | 12914 | 0.150 |
Why?
|
History, 21st Century | 1 | 2024 | 1575 | 0.150 |
Why?
|
Maryland | 1 | 2018 | 275 | 0.150 |
Why?
|
Antigens, Fungal | 1 | 2017 | 69 | 0.150 |
Why?
|
National Institute of Environmental Health Sciences (U.S.) | 1 | 2017 | 7 | 0.150 |
Why?
|
Alloys | 1 | 1998 | 113 | 0.150 |
Why?
|
Regional Medical Programs | 1 | 2018 | 68 | 0.150 |
Why?
|
Cost-Benefit Analysis | 2 | 2023 | 5508 | 0.150 |
Why?
|
Venoms | 1 | 2017 | 96 | 0.150 |
Why?
|
Inhalation Spacers | 1 | 2017 | 4 | 0.140 |
Why?
|
Bronchopulmonary Dysplasia | 1 | 2021 | 316 | 0.140 |
Why?
|
National Institute of Allergy and Infectious Diseases (U.S.) | 1 | 2017 | 62 | 0.140 |
Why?
|
Symbiosis | 1 | 2019 | 291 | 0.140 |
Why?
|
Glycoproteins | 2 | 2002 | 2208 | 0.140 |
Why?
|
Bedding and Linens | 1 | 2017 | 41 | 0.140 |
Why?
|
T-Lymphocytes, Regulatory | 3 | 2022 | 3075 | 0.140 |
Why?
|
Syncope | 1 | 2000 | 428 | 0.140 |
Why?
|
Polytetrafluoroethylene | 1 | 1998 | 245 | 0.140 |
Why?
|
Population | 1 | 2017 | 140 | 0.140 |
Why?
|
Antibodies, Neutralizing | 3 | 2023 | 1933 | 0.140 |
Why?
|
Body Weights and Measures | 1 | 2017 | 208 | 0.140 |
Why?
|
Th1-Th2 Balance | 1 | 2016 | 38 | 0.140 |
Why?
|
Organizations, Nonprofit | 1 | 2017 | 105 | 0.140 |
Why?
|
Sulfides | 3 | 2019 | 171 | 0.140 |
Why?
|
Bullying | 1 | 2019 | 221 | 0.130 |
Why?
|
Cyclopropanes | 3 | 2019 | 431 | 0.130 |
Why?
|
Antigens, Plant | 2 | 2021 | 104 | 0.130 |
Why?
|
Forecasting | 1 | 2005 | 2932 | 0.130 |
Why?
|
History, 20th Century | 1 | 2024 | 2773 | 0.130 |
Why?
|
Health Status Disparities | 2 | 2020 | 1830 | 0.130 |
Why?
|
Patient Preference | 1 | 2023 | 922 | 0.130 |
Why?
|
Longitudinal Studies | 7 | 2022 | 14495 | 0.130 |
Why?
|
Vitamin D | 4 | 2022 | 3291 | 0.130 |
Why?
|
Middle Aged | 28 | 2024 | 220352 | 0.130 |
Why?
|
Glutathione | 1 | 2018 | 582 | 0.130 |
Why?
|
Hospitalization | 7 | 2022 | 10790 | 0.130 |
Why?
|
Retrospective Studies | 13 | 2023 | 80372 | 0.120 |
Why?
|
Child Day Care Centers | 1 | 2016 | 122 | 0.120 |
Why?
|
Drug Resistance | 2 | 2019 | 1617 | 0.120 |
Why?
|
Sinusitis | 2 | 2013 | 990 | 0.120 |
Why?
|
Sex Factors | 4 | 2018 | 10547 | 0.120 |
Why?
|
Materials Testing | 1 | 1998 | 862 | 0.120 |
Why?
|
Insect Proteins | 1 | 2015 | 254 | 0.120 |
Why?
|
Arginine | 1 | 2018 | 934 | 0.120 |
Why?
|
Fluid Therapy | 1 | 2018 | 579 | 0.120 |
Why?
|
Standard of Care | 1 | 2018 | 552 | 0.120 |
Why?
|
Insect Control | 1 | 2014 | 29 | 0.120 |
Why?
|
Clinical Protocols | 3 | 2021 | 1440 | 0.120 |
Why?
|
Gonadal Steroid Hormones | 1 | 2018 | 701 | 0.110 |
Why?
|
Nebulizers and Vaporizers | 1 | 2014 | 137 | 0.110 |
Why?
|
Critical Pathways | 1 | 2017 | 475 | 0.110 |
Why?
|
Massachusetts | 3 | 2017 | 8803 | 0.110 |
Why?
|
PubMed | 1 | 2014 | 128 | 0.110 |
Why?
|
Antigens, Viral | 1 | 2017 | 980 | 0.110 |
Why?
|
Dietary Supplements | 3 | 2021 | 3392 | 0.110 |
Why?
|
Single-Blind Method | 1 | 2017 | 1578 | 0.110 |
Why?
|
Poverty Areas | 1 | 2015 | 264 | 0.110 |
Why?
|
Colony Count, Microbial | 1 | 2013 | 328 | 0.110 |
Why?
|
Immunoglobulin G | 2 | 2023 | 4541 | 0.110 |
Why?
|
Drug Therapy, Combination | 4 | 2022 | 6498 | 0.110 |
Why?
|
Administration, Topical | 1 | 2015 | 697 | 0.100 |
Why?
|
Primary Prevention | 2 | 2018 | 1207 | 0.100 |
Why?
|
Fever | 2 | 2016 | 1617 | 0.100 |
Why?
|
Cyclosporine | 1 | 2015 | 777 | 0.100 |
Why?
|
Antigens, Bacterial | 1 | 2017 | 1155 | 0.100 |
Why?
|
Vulnerable Populations | 1 | 2017 | 696 | 0.100 |
Why?
|
Skin Care | 1 | 2012 | 57 | 0.100 |
Why?
|
Perinatal Care | 1 | 2014 | 242 | 0.100 |
Why?
|
Self Report | 2 | 2022 | 3711 | 0.100 |
Why?
|
Soot | 2 | 2024 | 221 | 0.100 |
Why?
|
Cattle | 3 | 2024 | 3847 | 0.100 |
Why?
|
Faculty | 1 | 2015 | 383 | 0.100 |
Why?
|
Influenza, Human | 1 | 2022 | 1528 | 0.090 |
Why?
|
Cocos | 1 | 2010 | 9 | 0.090 |
Why?
|
Emergency Service, Hospital | 6 | 2023 | 7818 | 0.090 |
Why?
|
Tacrolimus | 1 | 2015 | 733 | 0.090 |
Why?
|
Anxiety | 2 | 2022 | 4538 | 0.090 |
Why?
|
Health Services Needs and Demand | 1 | 2018 | 1399 | 0.090 |
Why?
|
Drug Industry | 1 | 2017 | 789 | 0.090 |
Why?
|
Likelihood Functions | 1 | 2013 | 987 | 0.090 |
Why?
|
Dermatophagoides farinae | 1 | 2010 | 19 | 0.090 |
Why?
|
Dietary Proteins | 3 | 2021 | 949 | 0.090 |
Why?
|
New England | 1 | 2013 | 1050 | 0.090 |
Why?
|
Patient Acceptance of Health Care | 3 | 2019 | 3164 | 0.090 |
Why?
|
Metabolomics | 1 | 2019 | 1628 | 0.090 |
Why?
|
Anemia, Sickle Cell | 1 | 2018 | 1056 | 0.090 |
Why?
|
Th17 Cells | 1 | 2016 | 787 | 0.090 |
Why?
|
Forkhead Transcription Factors | 1 | 2017 | 1612 | 0.080 |
Why?
|
Mitosporic Fungi | 1 | 2009 | 17 | 0.080 |
Why?
|
CpG Islands | 1 | 2014 | 1221 | 0.080 |
Why?
|
Dose-Response Relationship, Drug | 5 | 2019 | 10827 | 0.080 |
Why?
|
Secondary Prevention | 1 | 2015 | 1548 | 0.080 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2024 | 3224 | 0.080 |
Why?
|
Ecosystem | 1 | 2013 | 485 | 0.080 |
Why?
|
Patient Selection | 1 | 2021 | 4283 | 0.080 |
Why?
|
Predictive Value of Tests | 3 | 2012 | 15289 | 0.080 |
Why?
|
Telemedicine | 2 | 2023 | 3018 | 0.080 |
Why?
|
Perception | 1 | 2015 | 1195 | 0.080 |
Why?
|
Income | 1 | 2017 | 1875 | 0.080 |
Why?
|
Rats | 2 | 2017 | 23711 | 0.080 |
Why?
|
Mental Health | 1 | 2022 | 3213 | 0.080 |
Why?
|
RNA Viruses | 1 | 2009 | 110 | 0.080 |
Why?
|
Pregnancy | 3 | 2022 | 29749 | 0.080 |
Why?
|
Tobacco Smoke Pollution | 1 | 2014 | 812 | 0.080 |
Why?
|
Follow-Up Studies | 4 | 2016 | 39261 | 0.080 |
Why?
|
Premature Birth | 1 | 2020 | 1771 | 0.080 |
Why?
|
Interleukin-13 | 2 | 2023 | 371 | 0.070 |
Why?
|
Humidity | 2 | 2021 | 205 | 0.070 |
Why?
|
Ambulatory Care | 1 | 2019 | 2781 | 0.070 |
Why?
|
Meta-Analysis as Topic | 1 | 2012 | 1376 | 0.070 |
Why?
|
Reproducibility of Results | 3 | 2021 | 20080 | 0.070 |
Why?
|
Administration, Oral | 3 | 2024 | 4035 | 0.070 |
Why?
|
Prosthesis Failure | 2 | 2006 | 1206 | 0.070 |
Why?
|
Receptors, Cell Surface | 1 | 2016 | 2825 | 0.070 |
Why?
|
Adrenal Cortex Function Tests | 1 | 2006 | 12 | 0.070 |
Why?
|
Environmental Pollution | 1 | 2008 | 123 | 0.070 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2016 | 2282 | 0.070 |
Why?
|
ROC Curve | 2 | 2012 | 3568 | 0.070 |
Why?
|
Disease Models, Animal | 4 | 2024 | 18137 | 0.070 |
Why?
|
Overweight | 1 | 2017 | 2421 | 0.070 |
Why?
|
Respiration Disorders | 1 | 2009 | 368 | 0.070 |
Why?
|
Rhinitis, Allergic, Perennial | 2 | 2013 | 59 | 0.070 |
Why?
|
Promoter Regions, Genetic | 2 | 2017 | 5785 | 0.070 |
Why?
|
Cytokines | 2 | 2023 | 7343 | 0.070 |
Why?
|
Biomedical Research | 2 | 2018 | 3426 | 0.070 |
Why?
|
Hot Temperature | 1 | 2012 | 1435 | 0.060 |
Why?
|
Analysis of Variance | 3 | 2020 | 6238 | 0.060 |
Why?
|
Health Services Accessibility | 1 | 2023 | 5397 | 0.060 |
Why?
|
Exercise Test | 1 | 2013 | 2128 | 0.060 |
Why?
|
Dehydroepiandrosterone Sulfate | 1 | 2006 | 240 | 0.060 |
Why?
|
Quantitative Trait Loci | 1 | 2014 | 2101 | 0.060 |
Why?
|
Nutrition Surveys | 2 | 2023 | 1725 | 0.060 |
Why?
|
Polysorbates | 1 | 2005 | 43 | 0.060 |
Why?
|
Fatty Acids, Essential | 1 | 2005 | 97 | 0.060 |
Why?
|
Carbon Monoxide | 2 | 2019 | 540 | 0.060 |
Why?
|
Disease Management | 1 | 2016 | 2514 | 0.060 |
Why?
|
Multivariate Analysis | 3 | 2018 | 12159 | 0.060 |
Why?
|
Hygiene | 1 | 2005 | 94 | 0.060 |
Why?
|
Inpatients | 1 | 2016 | 2581 | 0.060 |
Why?
|
Healthcare Disparities | 1 | 2020 | 3388 | 0.060 |
Why?
|
Anti-Bacterial Agents | 3 | 2021 | 7408 | 0.060 |
Why?
|
Prognosis | 3 | 2020 | 29658 | 0.060 |
Why?
|
Delivery of Health Care | 2 | 2022 | 5325 | 0.060 |
Why?
|
Models, Theoretical | 1 | 2016 | 3562 | 0.060 |
Why?
|
Adrenal Insufficiency | 1 | 2006 | 192 | 0.060 |
Why?
|
Hospital Mortality | 1 | 2018 | 5425 | 0.060 |
Why?
|
Computer Simulation | 1 | 1998 | 6218 | 0.060 |
Why?
|
Mice, Inbred BALB C | 2 | 2024 | 6216 | 0.060 |
Why?
|
Joint Prosthesis | 1 | 2006 | 253 | 0.060 |
Why?
|
Cost of Illness | 2 | 2024 | 1940 | 0.060 |
Why?
|
Age Distribution | 1 | 2010 | 2893 | 0.060 |
Why?
|
Critical Care | 1 | 2016 | 2699 | 0.060 |
Why?
|
Survival Analysis | 1 | 2016 | 10182 | 0.060 |
Why?
|
Specific Gravity | 1 | 2022 | 18 | 0.050 |
Why?
|
Registries | 1 | 2019 | 8469 | 0.050 |
Why?
|
Case-Control Studies | 3 | 2021 | 22053 | 0.050 |
Why?
|
Databases, Factual | 1 | 2018 | 8035 | 0.050 |
Why?
|
Respiratory Physiological Phenomena | 1 | 2023 | 188 | 0.050 |
Why?
|
Pituitary-Adrenal System | 2 | 2021 | 552 | 0.050 |
Why?
|
Receptors, Interleukin-4 | 1 | 2022 | 64 | 0.050 |
Why?
|
Puerto Rico | 1 | 2023 | 373 | 0.050 |
Why?
|
Fat Emulsions, Intravenous | 1 | 2005 | 314 | 0.050 |
Why?
|
Sulfonamides | 2 | 2024 | 1977 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3085 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3205 | 0.050 |
Why?
|
Metered Dose Inhalers | 1 | 2022 | 25 | 0.050 |
Why?
|
Seed Storage Proteins | 1 | 2021 | 15 | 0.050 |
Why?
|
Buprenorphine | 1 | 2010 | 654 | 0.050 |
Why?
|
Physicians | 1 | 2020 | 4591 | 0.050 |
Why?
|
Fish Oils | 1 | 2005 | 482 | 0.050 |
Why?
|
Hypothalamo-Hypophyseal System | 2 | 2021 | 700 | 0.050 |
Why?
|
2S Albumins, Plant | 1 | 2021 | 37 | 0.050 |
Why?
|
Administration, Intranasal | 1 | 2003 | 471 | 0.050 |
Why?
|
Heterocyclic Compounds, 3-Ring | 1 | 2024 | 279 | 0.050 |
Why?
|
Biological Therapy | 1 | 2023 | 139 | 0.050 |
Why?
|
Syndrome | 2 | 2020 | 3280 | 0.050 |
Why?
|
Histamine | 1 | 2023 | 498 | 0.050 |
Why?
|
Africa | 1 | 2023 | 705 | 0.050 |
Why?
|
Treatment Failure | 2 | 2020 | 2648 | 0.050 |
Why?
|
Drug Hypersensitivity | 1 | 2010 | 916 | 0.050 |
Why?
|
Health Personnel | 3 | 2023 | 3310 | 0.050 |
Why?
|
Purines | 1 | 2024 | 605 | 0.050 |
Why?
|
Infusions, Parenteral | 1 | 2021 | 399 | 0.050 |
Why?
|
Oxadiazoles | 1 | 2000 | 94 | 0.050 |
Why?
|
Evidence-Based Medicine | 3 | 2022 | 3696 | 0.050 |
Why?
|
Budesonide | 1 | 2021 | 158 | 0.050 |
Why?
|
Diet | 1 | 2018 | 8010 | 0.040 |
Why?
|
Phenylcarbamates | 1 | 2000 | 37 | 0.040 |
Why?
|
Delphi Technique | 1 | 2024 | 829 | 0.040 |
Why?
|
Carnobacteriaceae | 1 | 2019 | 10 | 0.040 |
Why?
|
Peptide Library | 1 | 2021 | 347 | 0.040 |
Why?
|
Aged | 9 | 2024 | 169152 | 0.040 |
Why?
|
Moraxella | 1 | 2019 | 25 | 0.040 |
Why?
|
Child Welfare | 1 | 2004 | 516 | 0.040 |
Why?
|
Androstadienes | 1 | 2021 | 348 | 0.040 |
Why?
|
Finland | 1 | 2021 | 603 | 0.040 |
Why?
|
Radioallergosorbent Test | 1 | 1999 | 19 | 0.040 |
Why?
|
Skin | 2 | 2024 | 4466 | 0.040 |
Why?
|
Intradermal Tests | 1 | 1999 | 42 | 0.040 |
Why?
|
Medical Records | 1 | 2005 | 1407 | 0.040 |
Why?
|
Staphylococcus | 1 | 2019 | 156 | 0.040 |
Why?
|
Streptococcus | 1 | 2019 | 198 | 0.040 |
Why?
|
Drug Synergism | 1 | 2003 | 1754 | 0.040 |
Why?
|
Time Factors | 2 | 2020 | 40165 | 0.040 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2021 | 629 | 0.040 |
Why?
|
Theophylline | 1 | 2019 | 131 | 0.040 |
Why?
|
Sulfur | 1 | 2019 | 163 | 0.040 |
Why?
|
Decontamination | 1 | 2019 | 72 | 0.040 |
Why?
|
Drug Administration Schedule | 2 | 2018 | 4899 | 0.040 |
Why?
|
Biomass | 1 | 2019 | 134 | 0.040 |
Why?
|
Prosthesis Design | 1 | 2006 | 2135 | 0.040 |
Why?
|
Antibody Formation | 1 | 2023 | 1400 | 0.040 |
Why?
|
Respiratory System | 1 | 2002 | 557 | 0.040 |
Why?
|
Geography | 1 | 2021 | 661 | 0.040 |
Why?
|
Consensus | 2 | 2023 | 3113 | 0.040 |
Why?
|
Smoking | 1 | 2015 | 9073 | 0.040 |
Why?
|
Carbon | 1 | 2022 | 669 | 0.040 |
Why?
|
Lubrication | 1 | 1998 | 21 | 0.040 |
Why?
|
Ventilation | 1 | 2019 | 128 | 0.040 |
Why?
|
Aluminum Oxide | 1 | 1998 | 41 | 0.040 |
Why?
|
Severe Combined Immunodeficiency | 1 | 2000 | 226 | 0.040 |
Why?
|
Ornithine | 1 | 2018 | 79 | 0.040 |
Why?
|
Age of Onset | 1 | 2005 | 3301 | 0.040 |
Why?
|
Prednisolone | 1 | 2019 | 327 | 0.040 |
Why?
|
Convalescence | 1 | 2018 | 106 | 0.040 |
Why?
|
Chronic Disease | 3 | 2022 | 9287 | 0.040 |
Why?
|
Cobalt | 1 | 1998 | 155 | 0.040 |
Why?
|
Steroids | 1 | 2003 | 928 | 0.040 |
Why?
|
Consensus Development Conferences, NIH as Topic | 1 | 2017 | 28 | 0.040 |
Why?
|
Clinical Trials, Phase III as Topic | 1 | 2021 | 861 | 0.040 |
Why?
|
Advisory Committees | 1 | 2021 | 788 | 0.040 |
Why?
|
Polysomnography | 1 | 2024 | 1825 | 0.040 |
Why?
|
Guideline Adherence | 1 | 2008 | 2283 | 0.040 |
Why?
|
Chromium | 1 | 1998 | 132 | 0.040 |
Why?
|
Acoustics | 1 | 1998 | 242 | 0.040 |
Why?
|
Trachea | 1 | 2023 | 1082 | 0.040 |
Why?
|
Creatinine | 1 | 2022 | 1903 | 0.030 |
Why?
|
Genotype | 2 | 2022 | 12960 | 0.030 |
Why?
|
Fund Raising | 1 | 2017 | 49 | 0.030 |
Why?
|
Mast Cells | 1 | 2024 | 1390 | 0.030 |
Why?
|
GRB2 Adaptor Protein | 1 | 2016 | 101 | 0.030 |
Why?
|
Nasal Cavity | 1 | 1998 | 304 | 0.030 |
Why?
|
Life Change Events | 1 | 2022 | 952 | 0.030 |
Why?
|
Acute Disease | 2 | 2018 | 7269 | 0.030 |
Why?
|
Vomiting | 1 | 2000 | 650 | 0.030 |
Why?
|
Aged, 80 and over | 4 | 2022 | 58995 | 0.030 |
Why?
|
Aftercare | 1 | 2022 | 916 | 0.030 |
Why?
|
Nurse's Role | 1 | 2017 | 188 | 0.030 |
Why?
|
Manometry | 1 | 1998 | 453 | 0.030 |
Why?
|
Appointments and Schedules | 1 | 2020 | 442 | 0.030 |
Why?
|
Absenteeism | 1 | 2017 | 250 | 0.030 |
Why?
|
Growth | 1 | 2018 | 365 | 0.030 |
Why?
|
Nigeria | 1 | 2019 | 762 | 0.030 |
Why?
|
Incidence | 2 | 2016 | 21392 | 0.030 |
Why?
|
Violence | 1 | 2022 | 927 | 0.030 |
Why?
|
High-Throughput Screening Assays | 1 | 2021 | 944 | 0.030 |
Why?
|
Ambulatory Care Facilities | 1 | 2022 | 926 | 0.030 |
Why?
|
Nuclear Receptor Subfamily 1, Group F, Member 3 | 1 | 2016 | 144 | 0.030 |
Why?
|
Evaluation Studies as Topic | 1 | 1998 | 1628 | 0.030 |
Why?
|
Immunophenotyping | 1 | 2020 | 1871 | 0.030 |
Why?
|
Gestational Age | 1 | 2004 | 3565 | 0.030 |
Why?
|
Reoperation | 1 | 2006 | 4291 | 0.030 |
Why?
|
Leukocytes, Mononuclear | 1 | 2022 | 1827 | 0.030 |
Why?
|
Receptors, Interleukin-6 | 1 | 2016 | 226 | 0.030 |
Why?
|
Surface Properties | 1 | 1998 | 1161 | 0.030 |
Why?
|
Puberty | 1 | 2018 | 498 | 0.030 |
Why?
|
Analgesics, Non-Narcotic | 1 | 2018 | 370 | 0.030 |
Why?
|
Fatigue | 1 | 2022 | 1544 | 0.030 |
Why?
|
Environmental Health | 1 | 2017 | 284 | 0.030 |
Why?
|
Carbon Dioxide | 1 | 2019 | 1146 | 0.030 |
Why?
|
Cough | 1 | 2018 | 595 | 0.030 |
Why?
|
Temperature | 1 | 2021 | 2221 | 0.030 |
Why?
|
Mouth Mucosa | 1 | 2017 | 426 | 0.030 |
Why?
|
Immunoglobulins, Intravenous | 1 | 2019 | 664 | 0.030 |
Why?
|
Breast Feeding | 1 | 2023 | 1355 | 0.030 |
Why?
|
Immunoprecipitation | 1 | 2016 | 877 | 0.030 |
Why?
|
Occupational Exposure | 1 | 2024 | 1809 | 0.030 |
Why?
|
Pyrazoles | 1 | 2024 | 1999 | 0.030 |
Why?
|
Proteins | 1 | 2009 | 6029 | 0.030 |
Why?
|
Population Surveillance | 1 | 2024 | 2608 | 0.030 |
Why?
|
Analgesics, Opioid | 1 | 2010 | 3763 | 0.030 |
Why?
|
Recurrence | 2 | 2016 | 8482 | 0.030 |
Why?
|
Risk Assessment | 2 | 2018 | 24123 | 0.030 |
Why?
|
Outpatients | 1 | 2022 | 1607 | 0.030 |
Why?
|
Diagnosis, Differential | 2 | 2018 | 12965 | 0.030 |
Why?
|
Drug Combinations | 1 | 2019 | 2025 | 0.030 |
Why?
|
Patient Care Management | 1 | 2016 | 303 | 0.030 |
Why?
|
Immunoblotting | 1 | 2016 | 1649 | 0.030 |
Why?
|
Clinical Trials as Topic | 1 | 2009 | 8056 | 0.030 |
Why?
|
Social Support | 1 | 2023 | 2145 | 0.030 |
Why?
|
Stress, Mechanical | 1 | 1998 | 1666 | 0.030 |
Why?
|
Logistic Models | 2 | 2004 | 13314 | 0.030 |
Why?
|
Dendritic Cells | 1 | 2024 | 2725 | 0.030 |
Why?
|
Adenosine Triphosphate | 1 | 2019 | 1993 | 0.030 |
Why?
|
Metabolome | 1 | 2019 | 982 | 0.030 |
Why?
|
T-Lymphocyte Subsets | 1 | 2020 | 1810 | 0.030 |
Why?
|
Cluster Analysis | 1 | 2019 | 2698 | 0.030 |
Why?
|
Pyrimidines | 1 | 2024 | 3016 | 0.020 |
Why?
|
STAT3 Transcription Factor | 1 | 2016 | 877 | 0.020 |
Why?
|
Europe | 1 | 2018 | 3441 | 0.020 |
Why?
|
Indoles | 1 | 2000 | 1829 | 0.020 |
Why?
|
Sex Distribution | 1 | 2017 | 2295 | 0.020 |
Why?
|
Qualitative Research | 1 | 2022 | 2963 | 0.020 |
Why?
|
C-Reactive Protein | 1 | 2023 | 3839 | 0.020 |
Why?
|
Water | 1 | 1998 | 1407 | 0.020 |
Why?
|
Research | 1 | 2020 | 1974 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2024 | 9530 | 0.020 |
Why?
|
Pediatrics | 1 | 2006 | 3586 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2017 | 3465 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 2 | 2018 | 17790 | 0.020 |
Why?
|
Administration, Sublingual | 1 | 2010 | 58 | 0.020 |
Why?
|
Interleukin-17 | 1 | 2016 | 910 | 0.020 |
Why?
|
Air Conditioning | 1 | 2009 | 54 | 0.020 |
Why?
|
Health Education | 1 | 2016 | 1049 | 0.020 |
Why?
|
Critical Illness | 1 | 2022 | 2709 | 0.020 |
Why?
|
Immunologic Factors | 1 | 2019 | 1588 | 0.020 |
Why?
|
Expert Testimony | 1 | 2012 | 361 | 0.020 |
Why?
|
Patient Discharge | 1 | 2022 | 3476 | 0.020 |
Why?
|
Program Evaluation | 1 | 2017 | 2493 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2021 | 3616 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2016 | 4573 | 0.020 |
Why?
|
Interferon-gamma | 1 | 2017 | 3157 | 0.020 |
Why?
|
Drug Resistance, Bacterial | 1 | 2015 | 1055 | 0.020 |
Why?
|
B-Lymphocytes | 1 | 2021 | 4742 | 0.020 |
Why?
|
Linear Models | 1 | 2018 | 5877 | 0.020 |
Why?
|
Gene Expression | 1 | 2020 | 7588 | 0.020 |
Why?
|
Odds Ratio | 1 | 2019 | 9716 | 0.020 |
Why?
|
Cosyntropin | 1 | 2006 | 34 | 0.020 |
Why?
|
Insurance, Health | 1 | 2019 | 2501 | 0.020 |
Why?
|
Exercise | 1 | 2023 | 5787 | 0.020 |
Why?
|
Flow Cytometry | 1 | 2016 | 5870 | 0.020 |
Why?
|
Genetic Variation | 1 | 2021 | 6551 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2016 | 6544 | 0.020 |
Why?
|
Mice, Inbred C57BL | 1 | 2024 | 22023 | 0.020 |
Why?
|
Proteomics | 1 | 2018 | 3817 | 0.020 |
Why?
|
Primary Health Care | 1 | 2021 | 4647 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2021 | 7850 | 0.010 |
Why?
|
Medicaid | 1 | 2017 | 2815 | 0.010 |
Why?
|
Neutrophils | 1 | 2017 | 3767 | 0.010 |
Why?
|
Diabetes Mellitus | 1 | 2020 | 5889 | 0.010 |
Why?
|
Pain | 1 | 2016 | 5066 | 0.010 |
Why?
|
Parenteral Nutrition | 1 | 2005 | 656 | 0.010 |
Why?
|
Hypertension | 1 | 2020 | 8594 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2016 | 9411 | 0.010 |
Why?
|
Oxazoles | 1 | 2000 | 199 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2016 | 11481 | 0.010 |
Why?
|
Hydrocortisone | 1 | 2006 | 1803 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2021 | 20509 | 0.010 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2005 | 1131 | 0.010 |
Why?
|
Body Height | 1 | 2004 | 1570 | 0.010 |
Why?
|
Energy Intake | 1 | 2005 | 2129 | 0.010 |
Why?
|
Bone Marrow Transplantation | 1 | 2005 | 2693 | 0.010 |
Why?
|
Patient Compliance | 1 | 2008 | 2688 | 0.010 |
Why?
|
Birth Weight | 1 | 2004 | 2097 | 0.010 |
Why?
|
Infant, Premature | 1 | 2004 | 2092 | 0.010 |
Why?
|
Feces | 1 | 2000 | 1455 | 0.010 |
Why?
|
RNA, Viral | 1 | 2000 | 2838 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2000 | 6068 | 0.010 |
Why?
|